ORBi: Detailled Reference

Article (Scientific journals)

Les antagonistes calciques ont-ils bien une place de première ligne dans le traitement de l'hypertension artérielle?

Krzesinski, Jean-Marie

2002 • In Revue Médicale de Liège, 57 (2), p. 79-84

Peer reviewed

Permalink
https://hdl.handle.net/2268/6075

PubMed
11942182

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Les antagonistes calciques ont ils bien une place de 1ère ligne.pdf

Publisher postprint (454.64 kB)

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Hypertension; Calcium antagonists; Treatment; INSIGHT study; Hypertension artérielle; Antagonistes calciques; Traitement; Etude INSIGHT

Abstract :

[en] During the nineties, a controversy was noted in the literature about the potential risk of using calcium antagonists in the treatment of hypertension. Several recent studies, such as the INSIGHT’s one have not confirmed this provided that one uses long-acting molecule. But the real beneficial effect due to the different antihypertensive classes is mainly linked to the magnitude of the blood pressure lowering effect.
[fr] Une controverse s’est installée dans les années 90 concernant le risque potentiel d’utilisation des antagonistes calciques dans le traitement de l’hypertension artérielle. Plusieurs études récentes, dont l’étude INSIGHT commentée ici, ont infirmé ce risque à condition d’utiliser des molécules à longue durée d’action. Il ressort cependant que le bénéfice à attendre des molécules antihypertensives passe avant tout par l’importance de l’abaissement tensionnel observé.

Disciplines :

Urology & nephrology

Author, co-author :

Krzesinski, Jean-Marie ; Université de Liège - ULiège > Département des sciences cliniques > Néphrologie

Language :

French

Title :

Les antagonistes calciques ont-ils bien une place de première ligne dans le traitement de l'hypertension artérielle?

Alternative titles :

[en] Have calcium antagonists a first line place for the treatement of arterial hypertension?

Publication date :

2002

Journal title :

Revue Médicale de Liège

ISSN :

0370-629X

eISSN :

2566-1566

Publisher :

Hopital de Baviere, Liège, Belgium

Volume :

57

Issue :

2

Pages :

79-84

Peer reviewed :

Peer reviewed

Available on ORBi :

since 11 February 2009

Statistics

Number of views

88 (6 by ULiège)

Number of downloads

154 (2 by ULiège)

More statistics

Scopus citations^®

2

Scopus citations^®
without self-citations

1

Bibliography

La place des médicaments dans le traitement de l'hypertension (2001) Folia Pharmaceutica, p. 11
Krzesinski, J.-M., Rorive, G.L., Les antagonistes des flux calciques dans le traitement de l'hypertension artérielle (1984) Rev Med Liège, 39, pp. 232-237
Collins, R., Peto, R., MacMahon, S., Blood pressure, stroke and coronary heart disease (1990) Lancet, 335, pp. 827-838
MacMahon, S., Peto, R., Cutler, J., Blood pressure, stroke and coronary heart disease. Part 1, prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias (1990) Lancet, 335, pp. 765-774
1999 World Health Organization-International Society of hypertension guidelines for the management of hypertension (1999) J Hypertens, 17, pp. 151-183
Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding (1997) J Hypertens, 15, pp. 105-115
Neaton, J., Grimm, R., Prineas, R., Treatment of mild hypertension study. Final study (1993) JAMA, 270, pp. 713-724
Abernethy, D., Schwartz, J.B., Calcium-antagonist drugs (1999) N Engl J Med, 341, pp. 1447-1457
Alderman, M.H., Cohen, H., Roqué, R., Madhavan, S., Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensives patients (1997) Lancet, 349, pp. 594-598
Dargie, H.J., Calcium-channel blockers: Managing uncertainty (1996) Lancet, 348, pp. 487-488
Gong, L., Zhang, W., Zhu, Y., Shanghai trial of nifedipine in the elderly (STONE) (1996) J Hypertens, 14, pp. 1237-1245
Staessen, J.A., Fagard, R., Thijs, L., Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension (1997) Lancet, 350, pp. 757-764
Brown, M.J., Palmer, C.R., Castaigne, A., Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT) (2000) Lancet, 356, pp. 366-372
Brown, M.J., Palmer, C.R., Castaigne, A., Principal results from the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT) (2001) Eur Heart J, 3 (SUPPL. B), pp. B20-B26
Chobanian, A.V., Can antihypertensive drugs reduce atherosclerosis and its clinical complications? (1994) Am J Hypertens, 7, pp. 119S-125S
Simon, A., Gariépy, J., Moyse, D., Differential effects of nifedipine and co-amilozide on the progression of early carotid wall changes (2001) Circulation, 103, pp. 2949-2954
Motro, M., Shemesh, J., Calcium channel blocker nifidepine slows down progression of coronary calcification in hypertensive patients compared with diuretics (2001) Hypertension, 37, pp. 1410-1413
Estacio, R., Jeffers, B., Hiat, W., The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension (1998) N Engl J Med, 338, pp. 645-652
Tuomilehto, J., Rastenyte, D., Birkenhäger, W., Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension (1999) N Engl J Med, 340, pp. 677-684
O'Leary, D.H., Polak, J.F., Kronmal, R.A., Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults (1999) N Engl J Med, 340, pp. 14-22
Borhani, N.O., Mercuri, M., Borhani, P.A., Final outcome results of the multicenter Isradipine diuretic atherosclerosis study (MIDAS) (1996) JAMA, 276, pp. 785-791
Borhani, N.O., (1995) Calcium antagonists and atherosclerosis: current status, new directions, pp. 545-548. , Elsevier Science BV
Pitt, B., Byington, R.P., Furberg, C.D., Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events (2000) Circulation, 102, pp. 1503-1510
Waters, D., Lespérance, J., Francetich, M., A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis (1990) Circulation, 82, pp. 1940-1953
Hansson, L., Hedner, T., Lund-Johansen, P., Effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: The Nordic Diltiazem (NORDIL) study (2000) Lancet, 356, pp. 359-365
Hansson, L., Lingholm, L.H., Niskanen, L., Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) randomised trial (1999) Lancet, 353, pp. 611-616
MacMahon, S., Neal, B., Differences between blood-pressure-lowering drugs (2000) Lancet, 356, pp. 352-353
Hansson, L., Lindholm, L.H., Ekbom, T., Randomised trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity the Swedish trial in old patients with hypertension-2 study (1999) Lancet, 354, pp. 1751-1756
Ruilope, L., Schifffrin, E., Blood pressure control and benefits of antihypertensive therapy - Does it make a difference which agents we use? (2001) Hypertension, 38 (PART 2), pp. 537-542
Staessen, J.A., Wang, J.I.-G., Thijs, L., Cardiovascular protection and blood pressure reduction (2001) Lancet, 358, pp. 1305-1315

Similar publications